Stein Steven H
CMO & Head of Late-Stage Dev.
Stein Steven H has filed 9 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jul 20, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.9M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| INCY | CMO & Head of Late-Stage Dev. | Sale | 1,877 | $215K | Jul 20 | SEC ↗ | |
| INCY | CMO & Head of Late-Stage Dev. | Sale | 28,237 | $3.2M | Jul 16 | SEC ↗ | |
| INCY | EVP & Chief Medical Officer | Sale | 15,634 | $1.6M | Jan 7 | SEC ↗ | |
| INCY | EVP & Chief Medical Officer | Sale | 2,559 | $263K | Dec 3 | SEC ↗ | |
| INCY | EVP & Chief Medical Officer | Sale | 20,105 | $2.1M | Dec 3 | SEC ↗ | |
| INCY | EVP & Chief Medical Officer | Sale | 5,233 | $535K | Nov 7 | SEC ↗ |